The Effect of Parecoxib Sodium Intravenous Patient-controlled Analgesia in Laparotomic Liver Resection
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The investigators hypothesized that using new intravenous infusion pump of patient-controlled
analgesia (parecoxib sodium 1 mg/mL + normal saline) would significantly improve
postoperative pain control compare to conventional intravenous infusion pump of
patient-controlled analgesia (fentanyl citrate 20 mg/mL/kg + ondansetron hydrochloride 16
mg/8 mL + normal saline). This prospective randomized controlled trial was designed to
evaluate the benefit of new intravenous infusion pump of patient-controlled analgesia
(parecoxib sodium 1 mg/mL + normal saline) for postoperative analgesia after laparotomic
liver resection.
Phase:
N/A
Details
Lead Sponsor:
First Affiliated Hospital of Harbin Medical University